The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Inflammation and cancer: An ancient link with novel potentials
Open accessAbstract
Infection and chronic inflammation contribute to about 1 in 4 of all cancer cases. Mediators of the inflammatory response, e.g., cytokines, free radicals, prostaglandins and growth factors, can induce genetic and epigenetic changes including point mutations in tumor suppressor genes, DNA methylation and post‐translational modifications, causing alterations in critical pathways responsible for maintaining the normal cellular homeostasis and leading to the development and progression of cancer. Recent discovery of an interaction between microRNAs and innate immunity during inflammation has further strengthened the association between inflammation and cancer. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1
Xu, Y., Zhu, K., Hong, G., Wu, W., Baudhuin, L. M., Xiao, Y.-J., & Damron, D. S. (2000) · Nature Cell Biology · doi:10.1038/35010529 · Cited by 289
RetractedBartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
Nitric oxide synthases: structure, function and inhibition
ALDERTON, W. K., COOPER, C. E., & KNOWLES, R. G. (2001) · Biochemical Journal · doi:10.1042/bj3570593 · Cited by 4,110
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Self-citationMicroRNAs Modulate Hematopoietic Lineage Differentiation
Chen, C.-Z., Li, L., Lodish, H. F., & Bartel, D. P. (2004) · Science · doi:10.1126/science.1091903 · Cited by 3,257
Podolsky, D. K. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020831 · Cited by 3,159
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1703 · Cited by 3,085
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.025 · Cited by 3,023
Self-citationAP-1 as a regulator of cell life and death
Shaulian, E., & Karin, M. (2002) · Nature Cell Biology · doi:10.1038/ncb0502-e131 · Cited by 2,961 · cited 1×
“ing cascade, leading to the induction of protooncogenes, including c-Fos and c-Jun, and AP-1-dependent gene expression involved in proliferation, differentiation, cell death and transformation.(15,16)”
BackgroundCyclooxygenase in biology and disease
DuBois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., van de Putte, L. B. A., & Lipsky, P. E. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,506
Prooxidant States and Tumor Promotion
Cerutti, P. A. (1985) · Science · doi:10.1126/science.2981433 · Cited by 2,497
Hypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,437
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
El-Omar, E. M., Carrington, M., Chow, W.-H., McColl, K. E. L., Bream, J. H., Young, H. A., Herrera, J., Lissowska, J., Yuan, C.-C., Rothman, N., et al. (2000) · Nature · doi:10.1038/35006081 · Cited by 2,366
Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
Tsujii, M., & DuBois, R. N. (1995) · Cell · doi:10.1016/0092-8674(95)90127-2 · Cited by 2,267
Paradoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256
Miranda, K. C., Huynh, T., Tay, Y., Ang, Y.-S., Tam, W.-L., Thomson, A. M., Lim, B., & Rigoutsos, I. (2006) · Cell · doi:10.1016/j.cell.2006.07.031 · Cited by 2,063
A cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940
MicroRNA-155 is induced during the macrophage inflammatory response
O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., & Baltimore, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610731104 · Cited by 1,866
Identification of hundreds of conserved and nonconserved human microRNAs
Bentwich, I., Avniel, A., Karov, Y., Aharonov, R., Gilad, S., Barad, O., Barzilai, A., Einat, P., Einav, U., Meiri, E., et al. (2005) · Nature Genetics · doi:10.1038/ng1590 · Cited by 1,841
Requirement of bic/microRNA-155 for Normal Immune Function
Rodriguez, A., Vigorito, E., Clare, S., Warren, M. V., Couttet, P., Soond, D. R., van Dongen, S., Grocock, R. J., Das, P. P., Miska, E. A., et al. (2007) · Science · doi:10.1126/science.1139253 · Cited by 1,833
Macrophage migration inhibitory factor: a regulator of innate immunity
Calandra, T., & Roger, T. (2003) · Nature Reviews Immunology · doi:10.1038/nri1200 · Cited by 1,795
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Hussain, S. P., Hofseth, L. J., & Harris, C. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1046 · Cited by 1,690 · cited 1×
“the field of cancer biology because of its proneoplastic and antineoplastic functions.(3,21) These antagonistic functions of NO are primarily governed by the quantity of NO , cell type, redox status and the inflammatory microenvironment.”
BackgroundSelf-citationCytokines in cancer pathogenesis and cancer therapy
Dranoff, G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1252 · Cited by 1,573
The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution
Farh, K. K.-H., Grimson, A., Jan, C., Lewis, B. P., Johnston, W. K., Lim, L. P., Burge, C. B., & Bartel, D. P. (2005) · Science · doi:10.1126/science.1121158 · Cited by 1,484
Regulation of the Germinal Center Response by MicroRNA-155
Thai, T.-H., Calado, D. P., Casola, S., Ansel, K. M., Xiao, C., Xue, Y., Murphy, A., Frendewey, D., Valenzuela, D., Kutok, J. L., et al. (2007) · Science · doi:10.1126/science.1141229 · Cited by 1,477
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
Das, P. M., & Singal, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.151 · Cited by 1,456
The role of cyclooxygenases in inflammation, cancer, and development
Williams, C. S., Mann, M., & DuBois, R. N. (1999) · Oncogene · doi:10.1038/sj.onc.1203286 · Cited by 1,417
Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
Tsujii, M., Kawano, S., & DuBois, R. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3336 · Cited by 1,398
Phylogenetic Shadowing and Computational Identification of Human microRNA Genes
Berezikov, E., Guryev, V., van de Belt, J., Wienholds, E., Plasterk, R. H. A., & Cuppen, E. (2005) · Cell · doi:10.1016/j.cell.2004.12.031 · Cited by 1,270
the Wellcome Trust Case Control Consortium, Parkes, M., Barrett, J. C., Prescott, N. J., Tremelling, M., Anderson, C. A., Fisher, S. A., Roberts, R. G., Nimmo, E. R., Cummings, F. R., et al. (2007) · Nature Genetics · doi:10.1038/ng2061 · Cited by 1,155
DNA methylation and gene silencing in cancer
Baylin, S. B. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0354 · Cited by 1,154
Epithelial NEMO links innate immunity to chronic intestinal inflammation
Nenci, A., Becker, C., Wullaert, A., Gareus, R., van Loo, G., Danese, S., Huth, M., Nikolaev, A., Neufert, C., Madison, B., et al. (2007) · Nature · doi:10.1038/nature05698 · Cited by 1,077
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
Gupta, R. A., & DuBois, R. N. (2001) · Nature Reviews Cancer · doi:10.1038/35094017 · Cited by 1,066
Inflammation, a Key Event in Cancer Development
Lu, H., Ouyang, W., & Huang, C. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0261 · Cited by 1,028
Human IRGM Induces Autophagy to Eliminate Intracellular Mycobacteria
Singh, S. B., Davis, A. S., Taylor, G. A., & Deretic, V. (2006) · Science · doi:10.1126/science.1129577 · Cited by 915
Prostaglandin E 2 Promotes Colon Cancer Cell Growth Through a G s -Axin-ß-Catenin Signaling Axis
Castellone, M. D., Teramoto, H., Williams, B. O., Druey, K. M., & Gutkind, J. S. (2005) · Science · doi:10.1126/science.1116221 · Cited by 883
IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy
Luo, J.-L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26322 · Cited by 878
Nitric oxide synthase: Aspects concerning structure and catalysis
Marletta, M. A. (1994) · Cell · doi:10.1016/0092-8674(94)90268-2 · Cited by 854
Budhu, A., Forgues, M., Ye, Q.-H., Jia, H.-L., He, P., Zanetti, K. A., Kammula, U. S., Chen, Y., Qin, L.-X., Tang, Z.-Y., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.06.016 · Cited by 846
Hypomethylation of DNA from Benign and Malignant Human Colon Neoplasms
Goelz, S. E., Vogelstein, B., Hamilton, S. R., & Feinberg, A. P. (1985) · Science · doi:10.1126/science.2579435 · Cited by 840
Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
Moore, R. J., Owens, D. M., Stamp, G., Arnott, C., Burke, F., East, N., Holdsworth, H., Turner, L., Rollins, B., Pasparakis, M., et al. (1999) · Nature Medicine · doi:10.1038/10552 · Cited by 839
Nod2 Mutation in Crohn's Disease Potentiates NF-κB Activity and IL-1ß Processing
Maeda, S., Hsu, L.-C., Liu, H., Bankston, L. A., Iimura, M., Kagnoff, M. F., Eckmann, L., & Karin, M. (2005) · Science · doi:10.1126/science.1103685 · Cited by 749
Maekita, T., Nakazawa, K., Mihara, M., Nakajima, T., Yanaoka, K., Iguchi, M., Arii, K., Kaneda, A., Tsukamoto, T., Tatematsu, M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2096 · Cited by 639
Accelerated age-related CpG island methylation in ulcerative colitis.
Issa, J. J., Ahuja, N., Toyota, M., Bronner, M. P., & Brentnall, T. A. (2001) · PubMed · Cited by 627
Perforin and interferon-γ activities independently control tumor initiation, growth, and metastasis
Street, S. E. A., Cretney, E., & Smyth, M. J. (2001) · Blood · doi:10.1182/blood.v97.1.192 · Cited by 572
Bartsch, H., & Nair, J. (2006) · Langenbeck's Archives of Surgery · doi:10.1007/s00423-006-0073-1 · Cited by 516
Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice.
Chulada, P. C., Thompson, M. B., Mahler, J. F., Doyle, C. M., Gaul, B. W., Lee, C., Tiano, H. F., Morham, S. G., Smithies, O., & Langenbach, R. J. (2000) · PubMed · Cited by 496
Inducible Nitric Oxide Synthase Binds, S-Nitrosylates, and Activates Cyclooxygenase-2
Kim, S. F., Huri, D. A., & Snyder, S. H. (2005) · Science · doi:10.1126/science.1119407 · Cited by 489
Hussain, S. P., Amstad, P., Raja, K., Ambs, S., Nagashima, M., Bennett, W. P., Shields, P. G., Ham, A. L., Swenberg, J. A., Marrogi, A. J., et al. (2000) · PubMed · Cited by 482
Self-citationAmbs, S., Merriam, W. G., Bennett, W. P., Felley‐Bosco, E., Ogunfusika, M. O., Oser, S. M., Klein, S., Shields, P. G., Billiar, T., & Harris, C. C. (1998) · PubMed · Cited by 472
Self-citationForrester, K., Ambs, S., Lupold, S. E., Kapust, R. B., Spillare, E. A., Weinberg, W. C., Felley-Bosco, E., Wang, X. W., Geller, D. A., Tzeng, E., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2442 · Cited by 469
Self-citationNitric Oxide and Cyclic GMP in Cell Signaling and Drug Development
Murad, F. (2006) · New England Journal of Medicine · doi:10.1056/nejmsa063904 · Cited by 420
Cytokines in cancer immunity and immunotherapy
Smyth, M. J., Cretney, E., Kershaw, M. H., & Hayakawa, Y. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00199.x · Cited by 412
Inflammation and Oxidative Stress in Carcinogenesis
Cerutti, P., & Amstad, P. (1993) · Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury · doi:10.1007/978-1-4615-3520-1_75 · Cited by 407
Mukaida, N., Harada, A., & Matsushima, K. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00022-1 · Cited by 401
Fontana, L., Pelosi, E., Greco, P., Racanicchi, S., Testa, U., Liuzzi, F., Croce, C. M., Brunetti, E., Grignani, F., & Peschle, C. (2007) · Nature Cell Biology · doi:10.1038/ncb1613 · Cited by 384
Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.
Smith, D. R., Polverini, P. J., Kunkel, S. L., Orringer, M. B., Whyte, R. I., Burdick, M. D., Wilke, C. A., & Strieter, R. M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1409 · Cited by 373
Chien, Y., Kim, S., Bumeister, R., Loo, Y.-M., Kwon, S. W., Johnson, C. L., Balakireva, M. G., Romeo, Y., Kopelovich, L., Gale, M., et al. (2006) · Cell · doi:10.1016/j.cell.2006.08.034 · Cited by 368
Inhibition of Cyclooxygenase-2 Gene Expression by p53
Subbaramaiah, K., Altorki, N., Chung, W. J., Mestre, J. R., Sampat, A., & Dannenberg, A. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10911 · Cited by 355
Nitric oxide-induced cellular stress and p53 activation in chronic inflammation
Hofseth, L. J., Saito, S., Hussain, S. P., Espey, M. G., Miranda, K. M., Araki, Y., Jhappan, C., Higashimoto, Y., He, P., Linke, S. P., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237083100 · Cited by 355
Self-citationMicroRNAs and Immunity: Tiny Players in a Big Field
Taganov, K. D., Boldin, M. P., & Baltimore, D. (2007) · Immunity · doi:10.1016/j.immuni.2007.02.005 · Cited by 343
Knight, B., Yeoh, G. C. T., Husk, K. L., Ly, T., Abraham, L. J., Yu, C., Rhim, J. A., & Fausto, N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1809 · Cited by 301
Chan, A. O.-O., Lam, S.-K., Wong, B. C.-Y., Wong, W.-M., Yuen, M.-F., Yeung, Y.-H., Hui, W.-M., Rashid, A., & Kwong, Y.-L. (2003) · Gut · doi:10.1136/gut.52.4.502 · Cited by 300
NF‐κB and cancer: Mechanisms and targets
Karin, M. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20217 · Cited by 298
Chemical biology of nitric oxide: Regulation and protective and toxic mechanisms
(1996) · Current Topics in Cellular Regulation · doi:10.1016/s0070-2137(96)80006-9 · Cited by 289
Thomas, D. D., Espey, M. G., Ridnour, L. A., Hofseth, L. J., Mancardi, D., Harris, C. C., & Wink, D. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400453101 · Cited by 289
Self-citationAmbs, S., Merriam, W. G., Ogunfusika, M. O., Bennett, W. P., Ishibe, N., Hussain, S. P., Tzeng, E. E., Geller, D. A., Billiar, T. R., & Harris, C. C. (1998) · Nature Medicine · doi:10.1038/3957 · Cited by 287
Self-citationRegulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
Araki, Y., Okamura, S., Hussain, S. P., Nagashima, M., He, P., Shiseki, M., Miura, K., & Harris, C. C. (2003) · PubMed · Cited by 285
Self-citationSchulmann, K., Sterian, A., Berki, A., Yin, J., Sato, F., Xu, Y., Olaru, A., Wang, S., Mori, Y., Deacu, E., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208598 · Cited by 259
Hussain, S. P., Raja, K., Amstad, P. A., Sawyer, M., Trudel, L. J., Wogan, G. N., Hofseth, L. J., Shields, P. G., Billiar, T. R., Trautwein, C., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220416097 · Cited by 248
Self-citationInterleukin-8/CXCL8 is a growth factor for human lung cancer cells
Zhu, Y. M., Webster, S. J., Flower, D., & Woll, P. J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602227 · Cited by 241
MicroRNAs in human cancer: from research to therapy
Negrini, M., Ferracin, M., Sabbioni, S., & Croce, C. M. (2007) · Journal of Cell Science · doi:10.1242/jcs.03450 · Cited by 239
Interleukin 6 Supports the Maintenance of p53 Tumor Suppressor Gene Promoter Methylation
Hodge, D. R., Peng, B., Cherry, J. C., Hurt, E. M., Fox, S. D., Kelley, J. A., Munroe, D. J., & Farrar, W. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3589 · Cited by 226
Wehbe, H., Henson, R., Meng, F., Mize-Berge, J., & Patel, T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2130 · Cited by 224
Interleukin 6 is essential for in vivo development of B lineage neoplasms.
Hilbert, D. M., Kopf, M., Mock, B. A., Köhler, G., & Rudikoff, S. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.243 · Cited by 222
p53-mediated induction of Cox-2 counteracts p53- or genotoxic stress-induced apoptosis
Han, J. A. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf591 · Cited by 214
Nitric oxide in cancer and chemoprevention
Hofseth, L. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01363-1 · Cited by 212
Meng, F., Henson, R., Wehbe-Janek, H., Smith, H., Ueno, Y., & Patel, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607712200 · Cited by 200
Global DNA hypomethylation increases progressively in cervical dysplasia and carcinoma
Kim, Y., Giuliano, A. R., Hatch, K. D., Schneider, A., Nour, M., Dallal, G. E., Selhub, J., & Mason, J. B. (1994) · Cancer · doi:10.1002/1097-0142(19940801)74:3<893::aid-cncr2820740316>3.0.co;2-b · Cited by 196
Deficiencies of GM-CSF and Interferon γ Link Inflammation and Cancer
Enzler, T., Gillessen, S., Manis, J. P., Ferguson, D., Fleming, J., Alt, F. W., Mihm, M., & Dranoff, G. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021258 · Cited by 179
What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis?
Fürstenberger, G., Krieg, P., Müller‐Decker, K., & Habenicht, A. J. R. (2006) · International Journal of Cancer · doi:10.1002/ijc.22153 · Cited by 172
Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice
Ambs, S., Ogunfusika, M. O., Merriam, W. G., Bennett, W. P., Billiar, T. R., & Harris, C. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8823 · Cited by 171
Self-citationWislez, M., Fujimoto, N., Izzo, J. G., Hanna, A. E., Cody, D. D., Langley, R. R., Tang, H., Burdick, M. D., Sato, M., Minna, J. D., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3842 · Cited by 164
CSF-1 and Its Receptor in Ovarian, Endometrial and Breast Cancer
Kacinski, B. M. (1995) · Annals of Medicine · doi:10.3109/07853899509031941 · Cited by 162
Pǒld, M., Zhu, L. X., Sharma, S. P., Burdick, M. D., Lin, Y., Lee, P. P. N., Põld, A., Luo, J., Krysan, K., Dohadwala, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3262 · Cited by 151
DNA Damage in Deoxynucleosides and Oligonucleotides Treated with Peroxynitrite
Burney, S., Niles, J. C., Dedon, P. C., & Tannenbaum, S. R. (1999) · Chemical Research in Toxicology · doi:10.1021/tx980254m · Cited by 150
Seike, M., Yanaihara, N., Bowman, E. D., Zanetti, K. A., Budhu, A., Kumamoto, K., Mechanic, L. E., Matsumoto, S., Yokota, J., Shibata, T., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm083 · Cited by 148
Self-citationValinluck, V., & Sowers, L. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0846 · Cited by 146
Marnett, L. J., Wright, T. L., Crews, B. C., Tannenbaum, S. R., & Morrow, J. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13427 · Cited by 141
Nitric Oxide, a Mediator of Inflammation, Suppresses Tumorigenesis
Hussain, S. P., Trivers, G. E., Hofseth, L. J., He, P., Shaikh, I. A., Mechanic, L. E., Doja, S., Jiang, W., Subleski, J. J., Shorts, L., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2201 · Cited by 131
Self-citationXu, W., Liu, L., Smith, G. C. M., & Charles, L. G. (2000) · Nature Cell Biology · doi:10.1038/35014028 · Cited by 127
Renner, P., Roger, T., & Calandra, T. (2005) · Clinical Infectious Diseases · doi:10.1086/432009 · Cited by 124
Vincent, T., Jourdan, M., Sy, M., Klein, B., & Mechti, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003965200 · Cited by 121
Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice.
(1997) · Europe PMC (PubMed Central) · Cited by 111
Regulation of Human Nitric Oxide Synthase 2 Expression by Wnt β-Catenin Signaling
Du, Q., Park, K. S., Guo, Z., He, P., Nagashima, M., Shao, L., Sahai, R., Geller, D. A., & Hussain, S. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4110 · Cited by 107
Nair, J., Gansauge, F., Beger, H. G., Dolara, P., Winde, G., & Bartsch, H. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.1003 · Cited by 106
Staib, F., Robles, A. I., Varticovski, L., Wang, X. W., Zeebèrg, B. R., Sirotin, M., Zhurkin, V. B., Hofseth, L. J., Hussain, S. P., Weinstein, J. N., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1714 · Cited by 103
Self-citationMechanisms of Cell Death Governed by the Balance between Nitrosative and Oxidative Stress
Espey, M. G., Miranda, K. M., Feelisch, M., Fukuto, J. M., Grisham, M. B., Vitek, M. P., & Wink, D. A. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06188.x · Cited by 100
Mechanisms for the Prevention of Gastrointestinal Cancer: The Role of Prostaglandin E2
Backlund, M. G., Mann, J. R., & DuBois, R. N. (2005) · Oncology · doi:10.1159/000086629 · Cited by 98
Peroxynitrite-induced DNA damage in the supF gene: correlation with the mutational spectrum
Tretyakova, N. Y., Burney, S., Pamir, B., Wishnok, J. S., Dedon, P. C., Wogan, G. N., & Tannenbaum, S. R. (2000) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(99)00221-3 · Cited by 96
Qin, Z., Kim, H. J., Hemme, J., & Blankenstein, T. J. F. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011887 · Cited by 79
Mutagenesis associated with nitric oxide production in macrophages
Zhuang, J. C., Lin, C., Lin, D., & Wogan, G. N. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8286 · Cited by 74
Tomimatsu, S., Ichikura, T., & Mochizuki, H. (2001) · Cancer · doi:10.1002/1097-0142(20010401)91:7<1272::aid-cncr1128>3.0.co;2-z · Cited by 63
Interleukin-6 inhibits radiation induced apoptosis in pancreatic cancer cells.
Miyamoto, Y., Hosotani, R., Doi, R., Wada, M., Ida, J., Tsuji, S., Kawaguchi, M., Nakajima, S., Kobayashi, H., Masui, T., et al. (2001) · PubMed · Cited by 56
Chronic Inflammation Promotes Retinoblastoma Protein Hyperphosphorylation and E2F1 Activation
Lei, Y., Marino, J., Hussain, S. P., Ma, K., You, S., Hofseth, A. B., Trivers, G. E., Dixon, D. A., Harris, C. C., & Hofseth, L. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1358 · Cited by 53
Self-citationAutocrine and Paracrine Regulation of Interleukin-8 Expression in Lung Cancer Cells
Yao, P., Lin, Y., Wang, C.-H., Huang, Y.-C., Liao, W., Wang, S., Chen, J. J. W., & Yang, P. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0223oc · Cited by 44
Nitric Oxide Is a Signaling Molecule that Regulates Gene Expression
Hofseth, L. J., Robles, A. I., Espey, M. G., & Harris, C. C. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)96027-8 · Cited by 17
Self-citationTatemichi, M., Tazawa, H., Masuda, M., Saleem, M., Wada, S., Donehower, L. A., Ohgaki, H., & Ohshima, H. (2004) · International Journal of Cancer · doi:10.1002/ijc.20350 · Cited by 17
Kim, M. Y., & Wogan, G. N. (2006) · Chemical Research in Toxicology · doi:10.1021/tx0601354 · Cited by 10
Cited by
Oxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
Chronic inflammation and cytokines in the tumor microenvironment
Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C., & Hermoso, M. A. (2014) · Journal of Immunology Research · doi:10.1155/2014/149185 · Cited by 1,765
Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
Lin, Y., Shi, R., Wang, X., & Shen, H.-M. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908786241050 · Cited by 1,169
Role of Antioxidants and Natural Products in Inflammation
Arulselvan, P., Fard, M. T., Tan, W. S., Gothai, S., Fakurazi, S., Norhaizan, M. E., & Kumar, S. S. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/5276130 · Cited by 1,005
MicroRNAs: the fine-tuners of Toll-like receptor signalling
O'Neill, L. A., Sheedy, F. J., & McCoy, C. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2957 · Cited by 856
Metadata
- Authors
- Perwez Hussain, S., & Harris, C. C.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2007-09-24
- Volume
- 121
- Issue
- 11
- Pages
- 2373-2380
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2007043238
- Cited by
- 1,097
- References
- 124
- FWCI
- 33.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.